| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 24.61▼ | 24.55▼ | 24.51▼ | 23.85▲ | 24.29▲ |
| MA10 | 24.64▼ | 24.48▲ | 24.30▲ | 24.36▲ | 23.77▲ |
| MA20 | 24.57▼ | 24.31▲ | 24.01▲ | 24.25▲ | 21.40▲ |
| MA50 | 24.43▲ | 23.97▲ | 23.92▲ | 23.46▲ | N/A |
| MA100 | 24.31▲ | 24.00▲ | 24.49▼ | 21.05▲ | N/A |
| MA200 | 23.95▲ | 24.44▲ | 24.28▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.023▼ | 0.019▲ | 0.075▲ | -0.132▼ | N/A |
| RSI | 46.398▼ | 55.435▲ | 56.684▲ | 53.277▲ | 64.522▲ |
| STOCH | 45.873 | 80.738▲ | 84.282▲ | 23.304 | 71.469 |
| WILL %R | -81.579▼ | -20.395▲ | -20.395▲ | -60.552 | -33.662 |
| CCI | -137.322▼ | 66.541 | 96.867 | -21.698 | 51.943 |
|
Thursday, March 26, 2026 01:04 PM
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
|
|
Wednesday, March 25, 2026 05:18 AM
LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S.NOVA-2 trial to enroll approximately 460 patientsPrimary ...
|
|
Friday, March 20, 2026 01:19 PM
CEO Heather Turner told investors the company is positioned for a series of “clinically meaningful value creating catalysts” following its most recent financing, with multiple late-stage readouts plan ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/03/26 | 24.10 | 24.79 | 23.27 | 24.48 | 208,113 |
| 25/03/26 | 23.52 | 24.595 | 22.84 | 24.21 | 172,319 |
| 24/03/26 | 23.45 | 23.67 | 22.48 | 23.37 | 122,709 |
| 23/03/26 | 23.53 | 24.47 | 23.47 | 23.67 | 129,378 |
| 20/03/26 | 23.98 | 24.46 | 23.26 | 23.53 | 778,701 |
| 19/03/26 | 23.60 | 24.24 | 23.05 | 23.99 | 225,257 |
| 18/03/26 | 24.05 | 24.53 | 23.325 | 23.76 | 309,210 |
| 17/03/26 | 26.51 | 26.51 | 24.17 | 24.42 | 395,436 |
| 16/03/26 | 25.77 | 27.55 | 25.77 | 26.46 | 383,209 |
| 13/03/26 | 25.19 | 26.65 | 25.19 | 25.67 | 296,343 |
|
|
||||
|
|
||||
|
|